Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
June 04 2020 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that John F.
Crowley, Chairman and Chief Executive Officer, will participate in
a fireside chat at the Goldman Sachs 41st Annual Global Healthcare
Conference, being held virtually on Wednesday, June 10, 2020 at
8:00 a.m. ET.
A live audio webcast of the presentation can also be accessed
via the Investors section of the Amicus Therapeutics corporate
website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow us on Twitter and
LinkedIn.
CONTACTS:
Investors/Media:Amicus TherapeuticsAndrew
FaughnanDirector, Investor Relationsafaughnan@amicusrx.com(609)
662-3809
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024